Menu Search

India

NX 100 Index - NSELast 5 days
Last price24,865.15
S&P/CNX 500Last 5 days
Last price22,193.80
S&P CNX Nifty Index - NSELast 5 days
Last price24,251.90
S&P CNX Defty - NSELast 5 days
Last price9,867.99
CNX IT Index - NSELast 5 days
Last price35,317.35
CNX Nifty Junior Index - NSELast 5 days
Last price65,898.15

Loading...

INR overview

PairLatest rateToday's change1 year change
INRGBP0.0088
GBP		-0.00003 / -0.34%--
INREUR0.0103
EUR		-0.00006 / -0.61%--
INRUSD0.0117
USD		-0.000005 / -0.04%--
INRJPY1.67
JPY		-0.0108 / -0.64%--
INRAUD0.0183
AUD		-0.00007 / -0.38%--
INRCAD0.0162
CAD		-0.00006 / -0.35%--
INRCNY0.0854
CNY		0.00008 / 0.09%--
INRCHF0.0097
CHF		-0.00005 / -0.55%--

Equity fund country flows

This chart shows the cumulative weekly equity in country flows into or out of India in USD. EPFR Global provides global coverage of foreign investor flows, tracking over 15,000 funds domiciled around the world.
As of May 19 2021.

Market movers

Constituents of the NX 100 Index - NSE with the highest percent gain over one day.
ListingLastChangeVolume
Divi's Laboratories LtdDIVISLAB:NSI6,222.00
INR		+297.50
+5.02%		1.47m
Indusind Bank LtdINDUSINDBK:NSI828.05
INR		+33.85
+4.26%		17.51m
GlaxoSmithKline Pharmaceuticals LtdGLAXO:NSI2,945.30
INR		+98.70
+3.47%		1.76m
ACC LtdACC:NSI2,113.00
INR		+61.10
+2.98%		617.97k
Sammaan Capital LtdSAMMAANCAP:NSI128.58
INR		+3.61
+2.89%		7.89m
Vedanta LtdVEDL:NSI427.45
INR		+9.25
+2.21%		9.33m
Aurobindo Pharma LtdAUROPHARMA:NSI1,273.70
INR		+26.90
+2.16%		887.64k
Federal Bank LtdFEDERALBNK:NSI203.62
INR		+3.85
+1.93%		7.48m
Oracle Financial Services Software LtdOFSS:NSI8,779.50
INR		+162.00
+1.88%		258.13k
Grasim Industries LtdGRASIM:NSI2,727.40
INR		+41.80
+1.56%		368.86k
Data delayed at least 15 minutes, as of Apr 24 2025 09:17 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.